SCHEMBL23760110

SCHEMBL23760110

COc1cc(O)cc(OC)c1N=C=S

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
CYP3A4 P08684 1/20 0.48
PTGS2 P35354 6/20 0.42
ALOX5 P09917 5/20 0.42
MAOB P27338 1/20 0.41
TDP1 Q9NUW8 2/20 0.35
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
CYP1A1 P04798 1/20 0.34
PTGS1 P23219 1/20 0.34
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
GABRA1 P14867 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14364245 0.76 MAOB (0.50) MAPTCYP3A4PTGS2ALOX5MAOB
SCHEMBL18245706 0.75 GABRA1 (0.48) MAPTCYP3A4TDP1TP53MAPK1
SCHEMBL14102097 0.72 MEN1 (0.47) CYP3A4GAAKMT2AGABRA1GABRB2
SCHEMBL9787173 0.72 MAPT (0.54) MAPTCYP3A4PTGS2ALOX5MAOB
SCHEMBL17764871 0.72 GABRA1 (0.37) CYP3A4TDP1NPC1SMN1; SMN2GAA
SCHEMBL23760097 0.72 GAA (0.46) MAPTCYP3A4PTGS2ALOX5NPC1
SCHEMBL5946226 0.72 ALOX15 (0.41) MAPTPTGS2ALOX5GABRA1GABRB2
SCHEMBL29327563 0.71 G6PD (0.50) MAPTMAPK1RAB9AGAAKMT2A
SCHEMBL28374773 0.68 TAAR1 (0.35) GABRA1GABRB2ESR1ESR2
SCHEMBL27215528 0.68 MAOB (0.50) MAPTCYP3A4PTGS2ALOX5MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230138393-A1 LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF, AND USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-04 US disclosed
WO-2021163467-A1 LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF, AND USE THEREOF TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230138393-A1 LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF, AND USE THEREOF BCAT2, BCAT1, AARS1 MAPT 865/4885CYP3A4 3480/4885PTGS2 3500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.